Mitochondrial function in ageing: Coordination with signalling and transcriptional pathways

Journal of Physiology

Volumn 594, Issue 8, 2016, Pages 2025-2042

  Yin, Fei ^a   Sancheti, Harsh ^a   Liu, Zhigang ^a   Cadenas, Enrique ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; PROTEIN P53; SIRTUIN 1; SOMATOMEDIN C; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTION FACTOR;

AGING; ALZHEIMER DISEASE; ASTROCYTE; BRAIN; BROWN ADIPOSE TISSUE; CELL FUNCTION; CENTRAL NERVOUS SYSTEM; CITRIC ACID CYCLE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; FATTY ACID METABOLISM; GLUCOSE METABOLISM; HEART; HOMEOSTASIS; HUMAN; LIVER; METABOLIC DISORDER; METABOLIC RATE; MITOCHONDRION; MOLECULAR MECHANICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; THERMOGENESIS; WHITE ADIPOSE TISSUE; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY;

AGING; ALZHEIMER DISEASE; ANIMALS; ENERGY METABOLISM; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MITOCHONDRIA; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84941767936     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP270541     Document Type: Review

References (195)

1. Aaronson RP & Woo E (1981). Organization in the cell nucleus: divalent cations modulate the distribution of condensed and diffuse chromatin. J Cell Biol 90, 181-186.
2. Ambs S, Ogunfusika MO, Merriam WG, Bennett WP, Billiar TR & Harris CC (1998). Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice. Proc Natl Acad Sci USA 95, 8823-8828.
3. Anantharaju A, Feller A & Chedid A (2002). Aging liver. Gerontology 48, 343-353.
4. Attardi G & Schatz G (1988). Biogenesis of mitochondria. Annu Rev Cell Biol 4, 289-331.
5. Baeuerle PA & Baltimore D (1996). NF-κB: ten years after. Cell 87, 13-20.
6. Barthwal MK, Sathyanarayana P, Kundu CN, Rana B, Pradeep A, Sharma C, Woodgett JR & Rana A (2003). Negative regulation of mixed lineage kinase 3 by protein kinase B/AKT leads to cell survival. J Biol Chem 278, 3897-3902.
7. Bélanger M, Allaman I & Magistretti PJ (2011). Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab 14, 724-738.
8. Bijur GN & Jope RS (2003). Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation. J Neurochem 87, 1427-1435.
9. Blass J, Sheu R & Gibson G (2000). Inherent abnormalities in energy metabolism in alzheimer disease: interaction with cerebrovascular compromise. Ann N Y Acad Sci 903, 204-221.
10. Bliss T & Collingridge G (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39.
11. Bolaños JP, Almeida A & Moncada S (2010). Glycolysis: a bioenergetic or a survival pathway? Trends Biochem Sci 35, 145-149.
12. Boveris A & Navarro A (2008). Brain mitochondrial dysfunction in aging. IUBMB Life 60, 308-314.
13. Brinton R (2008). Estrogen regulation of glucose metabolism and mitochondrial function: Therapeutic implications for prevention of Alzheimer's disease. Adv Drug Deliv Rev 60, 1504-1511.
14. Brouwer A, Barelds R & Knook D (1985). Age-related changes in the endocytic capacity of rat liver kupffer and endothelial cells. Hepatology 5, 362-366.
15. Brownlee M (2005). The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54, 1615-1625.
16. Busche M, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold K, Haass C, Staufenbiel M, Konnerth A & Garaschuk O (2008). Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Science 321, 1686-1689.
17. Businaro R, Ippoliti F, Ricci S, Canitano N & Fuso A (2012). Alzheimer's disease promotion by obesity: Induced mechanisms-Molecular links and perspectives. Curr Gerontol Geriatr Res 2012, 986823.
18. Calvo S, Jain M, Xie X, Sheth SA, Chang B, Goldberger OA, Spinazzola A, Zeviani M, Carr SA & Mootha VK (2006). Systematic identification of human mitochondrial disease genes through integrative genomics. Nat Genet 38, 576-582.
19. + metabolism and SIRT1 activity. Nature 458, 1056-1060.
20. Castro MdelR, Suarez E, Kraiselburd E, Isidro A, Paz J, Ferder L & Ayala-Torres S (2012). Aging increases mitochondrial DNA damage and oxidative stress in liver of rhesus monkeys. Exp Gerontol 47, 29-37.
21. Chan DC (2012). Fusion and fission: interlinked processes critical for mitochondrial health. Annu Rev Genet 46, 265-287.
22. Chavez JA, Holland WL, Bär J, Sandhoff K & Summers SA (2005). Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling. J Biol Chem 280, 20148-20153.
23. Chen X-L., Dodd G, Thomas S, Zhang X, Wasserman MA, Rovin BH & Kunsch C (2006). Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am J Physiol Heart Circ Physiol 290, H1862-H1870.
24. Cheng Z, Tseng Y & White MF (2010). Insulin signaling meets mitochondria in metabolism. Trends Endocrinol Metab 21, 589-598.
25. Christen Y (2000). Oxidative stress and Alzheimer disease. Am J Clin Nutr 71, 621s-629s.
26. Csiszar A, Wang M, Lakatta EG & Ungvari Z (2008). Inflammation and endothelial dysfunction during aging: role of NF-κB. J Appl Physiol 105, 1333-1341.
27. Cui J, Zhang M, Zhang YQ & Xu ZH (2007). JNK pathway: diseases and therapeutic potential. Acta Pharmacol Sin 28, 601-608.
28. Dax EM, Partilla JS & Gregerman RI (1981). Mechanism of the age-related decrease of epinephrine-stimulated lipolysis in isolated rat adipocytes: beta-adrenergic receptor binding, adenylate cyclase activity, and cyclic AMP accumulation. J Lipid Res 22, 934-943.
29. dela Monte SM (2012). Triangulated mal-signaling in Alzheimer's disease: Roles of neurotoxic ceramides, ER stress, and insulin resistance reviewed. J Alzheimers Dis 30, S231-S249.
30. dela Monte SM, Derdak Z & Wands JR (2012). Alcohol, insulin resistance and the liver-brain axis. J Gastroenterol Hepatol 27, 33-41.
31. dela Monte SM, Longato L, Tong M, DeNucci S & Wands JR (2009a). The liver-brain axis of alcohol-mediated neurodegeneration: role of toxic lipids. Int J Environ Res Public Health 6, 2055-2075.
32. dela Monte SM, Tong M, Lawton M & Longato L (2009b). Nitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment. Mol Neurodegener 4, 54.
33. dela Monte SM, Tong M, Nguyen V, Setshedi M, Longato L & Wands JR (2010). Ceramide-mediated insulin resistance and impairment of cognitive-motor functions. J Alzheimers Dis 21, 967-984.
34. De Matteis R, Lucertini F, Guescini M, Polidori E, Zeppa S, Stocchi V, Cinti S & Cuppini R (2013). Exercise as a new physiological stimulus for brown adipose tissue activity. Nutr Metab Cardiovasc Dis 23, 582-590.
35. de Mello VDF, Lankinen M, Schwab U, Kolehmainen M, Lehto S, Seppänen-Laakso T, Orešič M, Pulkkinen L, Uusitupa M & Erkkilä AT (2009). Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease. Diabetologia 52, 2612-2615.
36. Dedeoglu A, Choi J, Cormier K, Kowall N & Jenkins B (2004). Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile. Brain Res 1012, 60-65.
37. Delarue J & Magnan C (2007). Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care 10, 142-148.
38. Ding F, Yao J, Rettberg JR, Chen S & Brinton RD (2013a). Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: implication for bioenergetic intervention. PLoS One 8, e79977.
39. Ding F, Yao J, Zhao L, Mao Z, Chen S & Brinton RD (2013b). Ovariectomy induces a shift in fuel availability and metabolism in the hippocampus of the female transgenic model of familial Alzheimer's. PLoS One 8, e59825.
40. 13C-NMR spectroscopy of Thy-1-APPSL mice brain extracts indicates metabolic changes in Alzheimer's disease. J Neural Transm 122, 541-550.
41. Donato AJ, Henson GD, Hart CR, Layec G, Trinity JD, Bramwell RC, Enz RA, Morgan RG, Reihl KD, Hazra S, et al. (2014). The impact of ageing on adipose structure, function and vasculature in the B6D2F1 mouse: evidence of significant multisystem dysfunction. J Physiol 592, 4083-4096.
42. Drew B & Leeuwenburgh C (2004). Ageing and subcellular distribution of mitochondria: role of mitochondrial DNA deletions and energy production. Acta Physiol Scand 182, 333-341.
43. Dubois B, Feldman H, Jacova C, DeKosky S, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, et al. (2007). Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6, 734-746.
44. Dugan LL, You YH, Ali SS, Diamond-Stanic M, Miyamoto S, DeCleves AE, Andreyev A, Quach T, Ly S, Shekhtman G, et al. (2013). AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function. J Clin Invest 123, 4888-4899.
45. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, et al. (1999). Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283, 1544-1548.
46. Emerling BM, Weinberg F, Snyder C, Burgess Z, Mutlu GM, Viollet B, Budinger GR & Chandel NS (2009). Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP/ATP ratio. Free Radic Biol Med 46, 1386-1391.
47. Esteras N, Alquézar C, Bartolomé F, Antequera D, Barrios L, Carro E, Cerdán S & Martín-Requero Á (2012). Systematic evaluation of magnetic resonance imaging and spectroscopy techniques for imaging a transgenic model of Alzheimer's disease (AβPP/PS1). J Alzheimers Dis 30, 337-353.
48. Farkas E & Luiten P (2001). Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol 64, 575-611.
49. Fernandez-Marcos PJ & Auwerx J (2011). Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis. Am J Clin Nutr 93, 884S-890S.
50. Francis P, Palmer A, Snape M & Wilcock G (1999). The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry 66, 137-147.
51. Galindo M, Ikuta I, Zhu X, Casadesus G & Jordán J (2010). Mitochondrial biology in Alzheimer's disease pathogenesis. J Neurochem 114, 933-945.
52. Gerhart-Hines Z, Rodgers JT, Bare O, Lerin C, Kim SH, Mostoslavsky R, Alt FW, Wu Z & Puigserver P (2007). Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1α. EMBO J 26, 1913-1923.
53. Ghafourifar P & Cadenas E (2005). Mitochondrial nitric oxide synthase. Trends Pharmacol Sci 26, 190-195.
54. Gibson G, Sheu K & Blass J (1998). Abnormalities of mitochondrial enzymes in Alzheimer disease. J Neural Transm 105, 855-870.
55. Gill JMR & Sattar N (2009). Ceramides: A new player in the inflammation-insulin resistance paradigm? Diabetologia 52, 2475-2477.
56. Girard J & Lafontan M (2008). Impact of visceral adipose tissue on liver metabolism and insulin resistance. Part II: Visceral adipose tissue production and liver metabolism. Diabetes Metab 34, 439-445.
57. Gius D, Botero A, Shah S & Curry HA (1999). Intracellular oxidation/reduction status in the regulation of transcription factors NF-κB and AP-1. Toxicol Lett 106, 93-106.
58. Gottfries C, Adolfsson R, Aquilonius S, Carlsson A, Eckernas S, Nordberg A, Oreland L, Svennerholm L, Wiberg Å & Winblad B (1983). Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT). Neurobiol Aging 4, 261-271.
59. Graja A & Schulz TJ (2014). Mechanisms of aging-related impairment of brown adipocyte development and function. Gerontology 61, 211-217.
60. Hamann A, Flier JS & Lowell BB (1998). Obesity after genetic ablation of brown adipose tissue. Z Ernahrungswiss 37 Suppl 1, 1-7.
61. Handschin C & Spiegelman BM (2006). Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev 27, 728-735.
62. Haris M, Nath K, Cai K, Singh A, Crescenzi R, Kogan F, Verma G, Reddy S, Hariharan H, Melhem E, et al. (2013). Imaging of glutamate neurotransmitter alterations in Alzheimer's disease. NMR Biomed 26, 386-391.
63. Hauptmann S, Scherping I, Dröse S, Brandt U, Schulz K, Jendrach M, Leuner K, Eckert A & Müller W (2009). Mitochondrial dysfunction: An early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol Aging 30, 1574-1586.
64. Higami Y, Barger JL, Page GP, Allison DB, Smith SR, Prolla TA & Weindruch R (2006). Energy restriction lowers the expression of genes linked to inflammation, the cytoskeleton, the extracellular matrix, and angiogenesis in mouse adipose tissue. J Nutr 136, 343-352.
65. Higami Y, Pugh TD, Page GP, Allison DB, Prolla TA & Weindruch R (2004). Adipose tissue energy metabolism: altered gene expression profile of mice subjected to long-term caloric restriction. FASEB J 18, 415-417.
66. Højlund K, Mogensen M, Sahlin K & Beck-Nielsen H (2008). Mitochondrial dysfunction in type 2 diabetes and obesity. Endocrinol Metab Clin North Am 37, 713-731.
67. Hoshi M, Takashima A, Noguchi K, Murayama M, Sato M, Kondo S, Saitoh Y, Ishiguro K, Hoshino T & Imahori K (1996). Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase. kinase 3β in brain. Proc Natl Acad Sci USA 93, 2719-2723.
68. +: an old metabolite controlling new metabolic signaling pathways. Endocr Rev 31, 194-223.
69. Hur K-Y & Lee M-S (2015). New mechanisms of metformin action: focusing on mitochondria and the gut. J Diabetes Invest 6, 600-609.
70. Imhoff B & Hansen J (2009). Extracellular redox status regulates Nrf2 activation through mitochondrial reactive oxygen species. Biochem J 424, 491-500.
71. Iwakami S, Misu H, Takeda T, Sugimori M, Matsugo S, Kaneko S & Takamura T (2011). Concentration-dependent dual effects of hydrogen peroxide on insulin signal transduction in H4IIEC hepatocytes. PLoS One 6, e27401.
72. Jäger S, Handschin C, St-Pierre J & Spiegelman BM (2007). AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α. Proc Natl Acad Sci USA 104, 12017-12022.
73. Janssen-Heininger YMW, Poynter ME & Baeuerle PA (2000). Recent advances torwards understanding redox mechanisms in the activation of nuclear factor κb. Free Radic Biol Med 28, 1317-1327.
74. Janssen YMW, Heintz NH & Mossman BT (1995). Induction of c-fos and c-jun proto-oncogene expression by asbestos is ameliorated by N-acetyl-L-cysteine in mesothelial cells. Cancer Res 55, 2085-2089.
75. Jiang T & Cadenas E (2014). Astrocytic metabolic and inflammatory changes as a function of age. Aging Cell 13, 1059-1067.
76. Jiang T, Yin F, Yao J, Brinton RD & Cadenas E (2013). Lipoic acid restores age-associated impairment of brain energy metabolism through the modulation of Akt/JNK signaling and PGC1a transcriptional pathway. Aging Cell 12, 1021-1031.
77. Kabe Y, Ando K, Hirao S, Yoshida M & Handa H (2005). Redox regulation of NF-κB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal 7, 395-403.
78. Kanazawa I (2001). How do neurons die in neurodegenerative diseases? Trends Mol Med 7, 339-344.
79. Kann O & Kovács R (2007). Mitochondria and neuronal activity. Am J Physiol Cell Physiol 292, C641-C657.
80. Karpac J & Jasper H (2009). Insulin and JNK: optimizing metabolic homeostasis and lifespan. Trends Endocrinol Metab 20, 100-106.
81. Katic M, Kennedy AR, Leykin I, Norris A, McGettrick A, Gesta S, Russell SJ, Bluher M, Maratos-Flier E & Kahn CR (2007). Mitochondrial gene expression and increased oxidative metabolism: role in increased lifespan of fat-specific insulin receptor knock-out mice. Aging Cell 6, 827-839.
82. Kelley DE, He J, Menshikova EV & Ritov VB (2002). Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51, 2944-2950.
83. Kensler TW, Wakabayashi N & Biswal S (2007). Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47, 89-116.
84. Kim AH, Khursigara G, Sun X, Franke TF & Chao MV (2001a). Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol Cell Biol 21, 893-901.
85. Kim J, Cha Y-N & Surh Y-J (2010). A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders. Mutat Res 690, 12-23.
86. Kim JK, Fillmore JJ, Chen Y, Yu C, Moore IK, Pypaert M, Lutz EP, Kako Y, Velez-Carrasco W, Goldberg IJ, et al. (2001b). Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci USA 98, 7522-7527.
87. Klein S, Young VR, Blackburn GL, Bistrian BR & Wolfe RR (1986). Palmitate and glycerol kinetics during brief starvation in normal weight young adult and elderly subjects. J Clin Invest 78, 928-933.
88. Koh EH, Park JY, Park HS, Jeon MJ, Ryu JW, Kim M, Kim SY, Kim MS, Kim SW, Park IS, et al. (2007). Essential role of mitochondrial function in adiponectin synthesis in adipocytes. Diabetes 56, 2973-2981.
89. Kolosova N, Grishanova A, Krysanova Z, Zueva T, Sidorova I & Sinitsyna O (2003). [Age-related changes in protein and lipid oxidation in the liver of prematurely aging rats OXYS]. Biomed Khim 50, 73-78.
90. Kontani Y, Wang Y, Kimura K, Inokuma KI, Saito M, Suzuki-Miura T, Wang Z, Sato Y, Mori N & Yamashita H (2005). UCP1 deficiency increases susceptibility to diet-induced obesity with age. Aging Cell 4, 147-155.
91. Kujoth G, Hiona A, Pugh T, Someya S, Panzer K, Wohlgemuth S, Hofer T, Seo A, Sullivan R & Jobling W (2005). Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309, 481-484.
92. Lam PY, Yin F, Hamilton RT, Boveris A & Cadenas E (2009). Elevated neuronal nitric oxide synthase expression during ageing and mitochondrial energy production. Free Radic Res 43, 431-439.
93. Le Couteur D & McLean A (1998). The aging liver. Clin Pharmacokinet 34, 359-373.
94. Li C, Li Y, He L, Agarwal AR, Zeng N, Cadenas E & Stiles BL (2013). PI3K/AKT signaling regulates bioenergetics in immortalized hepatocytes. Free Radic Biol Med 60, 29-40.
95. 13C magnetic resonance spectroscopy study. MAGMA 16, 29-42.
96. Linseman DA, Phelps RA, Bouchard RJ, Le SS, Laessig TA, McClure ML & Heidenreich KA (2002). Insulin-like growth factor-I blocks Bcl-2 interacting mediator of cell death (Bim) induction and intrinsic death signaling in cerebellar granule neurons. J Neurosci 22, 9287-9297.
97. Loh K, Deng H, Fukushima A, Cai X, Boivin B, Galic S, Bruce C, Shields BJ, Skiba B, Ooms LM, et al. (2009). Reactive oxygen species enhance insulin sensitivity. Cell Metab 10, 260-272.
98. Lowell BB & Shulman GI (2005). Mitochondrial dysfunction and type 2 diabetes. Science 307, 384-387.
99. Lu RH, Ji H, Chang ZG, Su SS & Yang GS (2010). Mitochondrial development and the influence of its dysfunction during rat adipocyte differentiation. Mol Biol Rep 37, 2173-2182.
100. Luo F, Rustay N, Ebert U, Hradil V, Cole T, Llano D, Mudd S, Zhang Y, Fox G & Day M (2012). Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease. Neurobiol Aging 33, 933-944.
101. Maccioni R, Farías G, Morales I & Navarrete L (2010). The revitalized tau hypothesis on Alzheimer's disease. Arch Med Res 41, 226-231.
102. Magistretti PJ & Allaman I (2013). Brain energy metabolism. In Neuroscience in the 21st Century, ed. Pfaff DW, pp 1591-1620. Springer.
103. Mangialasche F, Solomon A, Winblad B, Mecocci P & Kivipelto M (2010). Alzheimer's disease: clinical trials and drug development. Lancet Neurol 9, 702-716.
104. Marjanska M, Curran G, Wengenack T, Henry P, Bliss R, Poduslo J, Jack C, Uğurbil K & Garwood M (2005). Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. Proc Natl Acad Sci USA 102, 11906-11910.
105. Markesbery W (1997). Oxidative stress hypothesis in alzheimer's disease. Free Radic Biol Med 23, 134-147.
106. 14C-labelled mitochondria is reduced in aged rats. Mech Ageing Dev 73, 157-168.
107. Masoro EJ (2005). Overview of caloric restriction and ageing. Mech Ageing Dev 126, 913-922.
108. McClean PL, Parthsarathy V, Faivre E & Hölscher C (2011). The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease. J Neurosci 31, 6587-6594.
109. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 12, 2005.
110. Moats R, Ernst T, Shonk T & Ross B (1994). Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn Reson Med 32, 110-115.
111. Mosconi L (2005). Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. Eur J Nucl Med Mol Imaging 32, 486-510.
112. Mosconi L, de Leon M, Murray J, Lu J, Javier E, McHugh P & Swerdlow R (2011). Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease. J Alzheimers Dis 27, 483-490.
113. Mosconi L, Mistur R, Switalski R, Tsui W, Glodzik L, Li Y, Pirraglia E, De Santi S, Reisberg B, Wisniewski T, et al. (2009). FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease. Eur J Nucl Med Mol Imaging 36, 811-822.
114. 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med 49, 390-398.
115. Muller-Hocker J, Aust D, Rohrbach H, Napiwotzky J, Reith A, Link T, Seibel P, Holzel D & Kadenbach B (1997). Defects of the respiratory chain in the normal human liver and in cirrhosis during aging. Hepatology 26, 709-719.
116. Murphy M (2009). How mitochondria produce reactive oxygen species. Biochem J 417, 1-13.
117. Navarro A & Boveris A (2004). Rat brain and liver mitochondria develop oxidative stress and lose enzymatic activities on aging. Am J Physiol Regul Integr Comp Physiol 287, R1244-R1249.
118. Navarro A & Boveris A (2007). The mitochondrial energy transduction system and the aging process. Am J Physiol Cell Physiol 292, C670-C686.
119. Ngo J, Pomatto L & Davies K (2013). Upregulation of the mitochondrial Lon Protease allows adaptation to acute oxidative stress but dysregulation is associated with chronic stress, disease, and aging. Redox Biol 1, 258-264.
120. Nilsen L, Rae C, Ittner L, Gotz J & Sonnewald U (2013). Glutamate metabolism is impaired in transgenic mice with tau hyperphosphorylation. J Cereb Blood Flow Metab 33, 684-691.
121. Nishikawa T & Araki E (2007). Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal 9, 343-353.
122. Nishikawa T, Brownlee M & Araki E (2015). Mitochondrial reactive oxygen species in the pathogenesis of early diabetic nephropathy. J Diabetes Investig 6, 137-139.
123. Nye C, Kim J, Kalhan SC & Hanson RW (2008). Reassessing triglyceride synthesis in adipose tissue. Trends Endocrinol Metab 19, 356-361.
124. Oakhill JS, Steel R, Chen ZP, Scott JW, Ling N, Tam S & Kemp BE (2011). AMPK is a direct adenylate charge-regulated protein kinase. Science 332, 1433-1435.
125. Oh-ishi S, Kizaki T, Toshinai K, Haga S, Fukuda K, Nagata N & Ohno H (1996). Swimming training improves brown-adipose-tissue activity in young and old mice. Mech Ageing Dev 89, 67-78.
126. Okita N, Hayashida Y, Kojima Y, Fukushima M, Yuguchi K, Mikami K, Yamauchi A, Watanabe K, Noguchi M, Nakamura M, et al. (2012). Differential responses of white adipose tissue and brown adipose tissue to caloric restriction in rats. Mech Ageing Dev 133, 255-266.
127. Owen MR, Doran E & Halestrap AP (2000). Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 348, 607-614.
128. Palmeira CM, Rolo AP, Berthiaume J, Bjork JA & Wallace KB (2007). Hyperglycemia decreases mitochondrial function: the regulatory role of mitochondrial biogenesis. Toxicol Appl Pharmacol 225, 214-220.
129. Parish R & Petersen KF (2005). Mitochondrial dysfunction and type 2 diabetes. Curr Diab Rep 5, 177-183.
130. Patti ME & Corvera S (2010). The role of mitochondria in the pathogenesis of type 2 diabetes. Endocr Rev 31, 364-395.
131. Perry E, Perry R, Tomlinson B, Blessed G & Gibson P (1980). Coenzyme a-acetylating enzymes in Alzheimer's disease: Possible cholinergic 'compartment' of pyruvate dehydrogenase. Neurosci Lett 18, 105-110.
132. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW & Shulman GI (2003). Mitochondrial dysfunction in the elderly: Possible role in insulin resistance. Science 300, 1140-1142.
133. Petersen KF, Dufour S, Befroy D, Garcia R & Shulman GI (2004). Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350, 664-671.
134. Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, Yu C, Cline GW, DePaoli AM, Taylor SI, Gorden P, et al. (2002). Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 109, 1345-1350.
135. Pfannenberg C, Werner MK, Ripkens S, Stef I, Deckert A, Schmadl M, Reimold M, Haring HU, Claussen CD & Stefan N (2010). Impact of age on the relationships of brown adipose tissue with sex and adiposity in humans. Diabetes 59, 1789-1793.
136. Piconi L, Quagliaro L, Assaloni R, Da Ros R, Maier A, Zuodar G & Ceriello A (2006). Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction. Diabetes Metab Res Rev 22, 198-203.
137. Poisnel G, Hérard A, El Tannir El Tayara N, Bourrin E, Volk A, Kober F, Delatour B, Delzescaux T, Debeir T, Rooney T, et al. (2012). Increased regional cerebral glucose uptake in an APP/PS1 model of Alzheimer's disease. Neurobiol Aging 33, 1995-2005.
138. Puigserver P & Spiegelman BM (2003). Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α): transcriptional coactivator and metabolic regulator. Endocr Rev 24, 78-90.
139. Puzzo D, Privitera L, Leznik E, Fà M, Staniszewski A, Palmeri A & Arancio O (2008). Picomolar amyloid-β positively modulates synaptic plasticity and memory in hippocampus. J Neurosci 28, 14537-14545.
140. Rahman I, Antonicelli F & MacNee W (1999). Molecular mechanism of the regulation of glutathione synthesis by tumor necrosis factor-α and dexamethasone in human alveolar epithelial cells. J Biol Chem 274, 5088-5096.
141. Rector RS, Thyfault JP, Uptergrove GM, Morris EM, Naples SP, Borengasser SJ, Mikus CR, Laye MJ, Laughlin MH, Booth FW, et al. (2010). Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. J Hepatol 52, 727-736.
142. Richter C (1995). Oxidative damage to mitochondrial DNA and its relationship to ageing. Int J Biochem Cell Biol 27, 647-653.
143. Rojas S, Herance J, Gispert J, Abad S, Torrent É, Jiménez X, Pareto D, Perpiña U, Sarroca S, Rodríguez E, et al. (2013). In vivo evaluation of amyloid deposition and brain glucose metabolism of 5XFAD mice using positron emission tomography. Neurobiol Aging 34, 1790-1798.
144. Root-Bernstein R, Busik JV & Henry DN (2002). Are diabetic neuropathy, retinopathy and nephropathy caused by hyperglycemic exclusion of dehydroascorbate uptake by glucose transporters? J Theor Biol 216, 345-359.
145. Rousset S, Alves-Guerra MC, Mozo J, Miroux B, Cassard-Doulcier AM, Bouillaud F & Ricquier D (2004). The biology of mitochondrial uncoupling proteins. Diabetes 53 Suppl 1, S130-135.
146. Saely CH, Geiger K & Drexel H (2012). Brown versus white adipose tissue: a mini-review. Gerontology 58, 15-23.
147. Saito M, Okamatsu-Ogura Y, Matsushita M, Watanabe K, Yoneshiro T, Nio-Kobayashi J, Iwanaga T, Miyagawa M, Kameya T, Nakada K, et al. (2009). High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes 58, 1526-1531.
148. Salek R, Xia J, Innes A, Sweatman B, Adalbert R, Randle S, McGowan E, Emson P & Griffin J (2010). A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease. Neurochem Int 56, 937-947.
149. Saltiel AR & Kahn CR (2001). Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414, 799-806.
150. Sancheti H, Akopian G, Yin F, Brinton RD, Walsh JP & Cadenas E (2013). Age-dependent modulation of synaptic plasticity and insulin mimetic effect of lipoic acid on a mouse model of Alzheimer's disease. PLoS One 8, e69830.
151. 13C NMR study. J Cereb Blood Flow Metab 34, 288-296.
152. Sancheti H, Patil I, Kanamori K, Diaz Brinton R, Zhang W, Lin A & Cadenas E (2014b). Hypermetabolic state in the 7-month-old triple transgenic mouse model of Alzheimer's disease and the effect of lipoic acid: a 13C-NMR study. J Cereb Blood Flow Metab 34, 1749-1760.
153. Sandireddy R, Yerra VG, Areti A, Komirishetty P & Kumar A (2014). Neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets. Int J Endocrinol 2014, 674987.
154. Sastre J, Pallardó F, Plá R, Pellín A, Juan G, O'Connor J, Estrela J, Miquel J & Viña J (1996). Aging of the liver: Age-associated mitochondrial damage in intact hepatocytes. Hepatology 24, 1199-1205.
155. Sastre J, Pallardó F & Viña J (2000). Mitochondrial oxidative stress plays a key role in aging and apoptosis. IUBMB Life 49, 427-435.
156. Scarpace PJ, Yenice S & Tumer N (1994). Influence of exercise training and age on uncoupling protein mRNA expression in brown adipose tissue. Pharmacol Biochem Behav 49, 1057-1059.
157. Scarpulla RC (2002). Nuclear activators and coactivators in mammalian mitochondrial biogenesis. Biochim Biophys Acta 1576, 1-14.
158. Schmucker D (1998). Aging and the liver: an update. J Gerontol A Biol Sci Med Sci 53A, B315-B321.
159. Seo AY, Joseph AM, Dutta D, Hwang JC, Aris JP & Leeuwenburgh C (2010). New insights into the role of mitochondria in aging: mitochondrial dynamics and more. J Cell Sci 123, 2533-2542.
160. Shi T, Wang F, Stieren E & Tong Q (2005). SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J Biol Chem 280, 13560-13567.
161. Storozhevykh TP, Senilova YE, Persiyantseva NA, Pinelis VG & Pomytkin IA (2007). Mitochondrial respiratory chain is involved in insulin-stimulated hydrogen peroxide production and plays an integral role in insulin receptor autophosphorylation in neurons. BMC Neurosci 8, 84.
162. Summers SA (2006). Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 45, 42-72.
163. Sun XZ, Vinci C, Makmura L, Han S, Tran D, Nguyen J, Hamann M, Grazziani S, Sheppard S & Gutova M (2003). Formation of disulfide bond in p53 correlates with inhibition of DNA binding and tetramerization. Antioxid Redox Signal 5, 655-665.
164. Swerdlow R (2011). Brain aging, Alzheimer's disease, and mitochondria. Biochim Biophys Acta 1812, 1630-1639.
165. Swerdlow R & Khan S (2009). The Alzheimer's disease mitochondrial cascade hypothesis: An update. Exp Neurol 218, 308-315.
166. Tanzi R & Bertram L (2005). Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective. Cell 120, 545-555.
167. Teruel T, Hernandez R & Lorenzo M (2001). Ceramide mediates insulin resistance by tumor necrosis factor-α in brown adipocytes by maintaining Akt in an inactive dephosphorylated state. Diabetes 50, 2563-2571.
168. Tiwari V & Patel A (2012). Impaired glutamatergic and GABAergic function at early age in AβPPswe-PS1dE9 mice: Implications for Alzheimer's disease. J Alzheimers Dis 28, 765-769.
169. Tormos KV, Anso E, Hamanaka RB, Eisenbart J, Joseph J, Kalyanaraman B & Chandel NS (2011). Mitochondrial complex III ROS regulate adipocyte differentiation. Cell Metab 14, 537-544.
170. Trayhurn P & Wood IS (2004). Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92, 347-355.
171. Twig G & Shirihai OS (2011). The interplay between mitochondrial dynamics and mitophagy. Antioxid Redox Signal 14, 1939-1951.
172. Valle A, Guevara R, Garcia-Palmer FJ, Roca P & Oliver J (2008). Caloric restriction retards the age-related decline in mitochondrial function of brown adipose tissue. Rejuvenation Res 11, 597-604.
173. van der Heide LP, Ramakers GM & Smidt MP (2006). Insulin signaling in the central nervous system: learning to survive. Prog Neurobiol 79, 205-221.
174. van Duijn S, Nabuurs R, van Duinen S, Natté R, van Buchem M & Alia A (2013). Longitudinal monitoring of sex-related in vivo metabolic changes in the brain of Alzheimer's disease transgenic mouse using magnetic resonance spectroscopy. J Alzheimers Dis 34, 1051-1059.
175. Virtanen KA, Lidell ME, Orava J, Heglind M, Westergren R, Niemi T, Taittonen M, Laine J, Savisto NJ, Enerback S, et al. (2009). Functional brown adipose tissue in healthy adults. N Engl J Med 360, 1518-1525.
176. Wartewig S & Neubert RHH (2007). Properties of ceramides and their impact on the stratum corneum structure: A review. Skin Pharmacol Physiol 20, 220-229.
177. White MF (2003). Insulin signaling in health and disease. Science 302, 1710-1711.
178. Wikstrom JD, Mahdaviani K, Liesa M, Sereda SB, Si Y, Las G, Twig G, Petrovic N, Zingaretti C, Graham A, et al. (2014). Hormone-induced mitochondrial fission is utilized by brown adipocytes as an amplification pathway for energy expenditure. EMBO J 33, 418-436.
179. Wynne H, Cope L, Mutch E, Rawlins M, Woodhouse K & James O (1989). The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 9, 297-301.
180. Xiao B, Sanders MJ, Underwood E, Heath R, Mayer FV, Carmena D, Jing C, Walker PA, Eccleston JF, Haire LF, et al. (2011). Structure of mammalian AMPK and its regulation by ADP. Nature 472, 230-233.
181. Yao J, Irwin R, Zhao L, Nilsen J, Hamilton R & Brinton R (2009). Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 106, 14670-14675.
182. Yen T, Chen Y, King K, Yeh S & Wei Y (1989). Liver mitochondrial respiratory functions decline with age. Biochem Biophys Res Commun 165, 994-1003.
183. Yin F, Boveris A & Cadenas E (2014). Mitochondrial energy metabolism and redox signaling in brain aging and neurodegeneration. Antioxid Redox Signal 20, 353-371.
184. Yin F & Cadenas E (2015). Mitochondria: the cellular hub of the dynamic coordinated network. Antioxid Redox Signal 22, 961-964.
185. Yin F, Jiang T & Cadenas E (2013). Metabolic triad in brain aging: mitochondria, insulin/IGF-1 signalling, and JNK signalling. Biochem Soc Trans 41, 101-105.
186. Yin F, Sancheti H & Cadenas E (2012a). Mitochondrial thiols in the regulation of cell death pathways. Antioxid Redox Signal 17, 1714-1727.
187. Yin F, Sancheti H & Cadenas E (2012b). Silencing of nicotinamide nucleotide transhydrogenase impairs cellular redox homeostasis and energy metabolism in PC12 cells. Biochim Biophys Acta 1817, 401-409.
188. Yin F, Yao J, Sancheti H, Feng T, Melcangi RC, Morgan TE, Finch CE, Pike CJ, Mack WJ, Cadenas E, et al. (2015). The perimenopausal aging transition in the female rat brain: decline in bioenergetic systems and synaptic plasticity. Neurobiol Aging 36, 2282-2295.
189. Zheng W, Kollmeyer J, Symolon H, Momin A, Munter E, Wang E, Kelly S, Allegood JC, Liu Y, Peng Q, et al. (2006). Ceramides and other bioactive sphingolipid backbones in health and disease: Lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Biochim Biophys Acta 1758, 1864-1884.
190. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, et al. (2001). Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108, 1167-1174.
191. Zhou Q, Lam PY, Han D & Cadenas E (2008). c-Jun N-terminal kinase regulates mitochondrial bioenergetics by modulating pyruvate dehydrogenase activity in primary cortical neurons. J Neurochem 104, 325-335.
192. Zhou Q, Lam PY, Han D & Cadenas E (2009). Activation of C-Jun-N-terminal kinase and decline of mitochondrial pyruvate dehydrogenase activity during brain aging. FEBS Lett 583, 1132-1140.
193. Zhuang J, Ma W, Lago CU & Hwang PM (2012). Metabolic regulation of oxygen and redox homeostasis by p53: Lessons from evolutionary biology? Free Radic Biol Med 53, 1279-1285.
194. Zingaretti MC, Crosta F, Vitali A, Guerrieri M, Frontini A, Cannon B, Nedergaard J & Cinti S (2009). The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue. FASEB J 23, 3113-3120.
195. Zmijewski JW, Banerjee S, Bae H, Friggeri A, Lazarowski ER & Abraham E (2010). Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase. J Biol Chem 285, 33154-33164.